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Abstract 
Studies have shown that metabolic risk factors associated with increased body mass index are 
the critical factors that confer risk for the chronic diseases associated with fat. The prevalence 
of these disorders is scarcely reported in Nigeria. We evaluated 542 adult Nigerians for 
nutritional status, serum total cholesterol, fasting blood glucose level and hypertension, using 
standard anthropometric and clinical methods. The results show that 32.1%, 11.8%, 19.6%, 
11.8% and 60.7% of the population, irrespective of sex were over-weight, obese, 
hyperglycaemic, hypercholesterolemic and hypertensive respectively. Approximately 33% of 
the obese population were metabolically-healthy obese-like (MHO-like) while 8.6% of the 
normal BMI population were metabolically-obese normal-weight-like (MONW-like). Other 
sub-phenotypes were present at rates of 5 – 32% in the population. The results are discussed 
and compared to figures from other populations. Our data apparently supports the view that 
the assessment of metabolic risks for chronic diseases, irrespective of body mass index, may 
be more useful in identifying individuals or groups at risk of these disorders. 
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Overweight and obesity are increasing at an 
alarming rate globally and developing 
countries appear to be the worst hit
1
 despite an 
increased awareness of the deleterious 
consequences of these conditions. Both 
disorders are often consequences of an 
imbalance in the energy intake and 
expenditure
2,3 
and are described by a body 
mass index (BMI) of 25-29.9 kg m
-2
 (over-
weight) and more than 30 kg m
-2
 (obese).  
 
Obesity is a major risk factor for the 
development of chronic diseases and the 
associated mortality4,5. Visceral fat 
accumulation, which often accompany obesity, 
is associated with increased secretion of free 
fatty acids, hyperinsulinaemia, insulin 
resistance, hypertension, hyperglyceamia and 
dyslipidaemia6,7.  
 
Insulin resistance, which is an impaired 
biological response to insulin, is compensated 
for initially by the system, by an increased 
production of insulin such that with sustained 
insulin production and release, 
hyperinsulinaemia results. Since insulin stops 
the action of hormone sensitive lipase and 
lowers the level of carnithine in the liver, 
hyperinsulinaemia enhances the development 
of obesity
8,9
. This cyclic relationship may in 
part explain the difficulty observed in losing 
weight and sustaining such weight-loss in 
overweight and obese individuals, a 
phenomenon called weight cycling. 
 
Obesity is a complex disorder, involving the 
interaction of genetics with environmental 
factors to produce a heterogenous phenotype
10
. 
Studies have identified metabolically obese 
normal-weight (MONW) individuals who 
despite having a normal weight BMI, still have 
metabolic disturbances typical of obese 
individuals
11-13
.   
 
Other studies have described metabolically 
healthy obese (MHO) individuals, who, 
despite having BMI exceeding 30 kg m-2, still 
lack the metabolic abnormalities typical of 
obese individuals
14-16
. These phenotypes 
separate obesity from its usual metabolic 
consequences as seen in MONW individuals, 
or risks that are associated with obesity that 
are independent of adiposity as seen in MHO 
individuals. 
The prevalence of BMI-metabolic risk sub-
phenotypes in community-based samples, 
especially in Africa, and Nigeria in particular 
is not known. The aim of this study is to 
provide data on: the nutritional status of adult 
Nigerians; the prevalence of hyperglyceamia 
and hypercholesterolemia in the population; 
and the prevalence of MONW-like and MHO-
like individuals in the population. 
 
MATERIALS AND METHODS 
 
Adult Nigerian men and women (30-74 years 
of age) were studied. The participants were 
from Anyigba, Kogi State and Nsukka, Enugu 
State – both states are geographically 
contiguous with Kogi State bordering Enugu 
State to the North. The study was advertised 
locally in the two towns and those who gave 
informed verbal consent were allowed to 
participate in the study.The weights and 
heights of participants were taken, with 
subjects dressed in light clothing and the BMI 





as thin (BMI<18.5), normal 
(18.5 ≤ BMI ≤ 24.9), overweight (25 ≤ BMI ≤ 
29.9) and obese (BMI ≥ 30). 
 
Fasting blood samples (2ml) were drawn from 
each participant using a 4ml syringe, and 
transferred into clean sample containers. A 
drop of whole blood was removed from each 
container immediately and used for the 
measurement of whole blood glucose, by the 
glucose oxidase method18, using a glucometre 
(Accu-Chek Advantage, Roche Diagnostics, 
Mannheim, Germany). The glucometre was 
calibrated using standard test strips and 
solutions supplied by the manufacturer. Blood 
samples were allowed to stand at ambient 
temperature until clotting took place. The 
serum was separated completely by 
centrifugation for 5 minutes. From the serum, 
the total cholesterol concentration was 




Subjects were grouped as being normo-
cholesterolemic if they had cholesterol values 
of less than 5.17 mmol/L, and as being hyper-
cholesterolemic20 if they had values ≥5.17 
mmol/L. Subjects who had a fasting blood 
glucose level of >115 mg/dL were classified as 
having hyperglyceamia while those who had 
blood glucose levels ≤115 mg/dL were 
classified as having normal blood glucose 
19 
 
levels. Those with hyperglyceamia were 
further divided into those with impaired 
fasting blood glucose levels (115 mg/dL to 
<125 mg/dL) and diabetic subjects (≥125 
mg/dL)
20
. Age at last birthday as reported by 
each participant, was recorded. Blood pressure 
was measured using a digital blood pressure 
monitor (Omron model HEM-741 CINT, 
Omron Healthcare Inc., Illinois, USA). Three 
separate readings were taken (after a two 
minutes interval each) per individual (in a 
sitting position after an initial ten minutes rest) 
and the average of the second and third 
readings recorded. High blood pressure was 
defined as mean systolic blood pressure (SBP) 
≥ 140mmHg and/or a mean diastolic blood 





Subjects who had a cluster of 
hypercholesterolemia, hyperglycaemia and 
hypertension were described as metabolically-
obese-like, while those who had normal values 
for the three parameters were described as 
metabolically-healthy-like. Based their BMI, 




obese obese-like (MOO-like); metabolically-
healthy normal-weight-like (MHNW-like); 
metabolically-healthy over-weight-like 
(MHOW-like); and metabolically-healthy 
obese-like (MHO-like) sub-phenotypes.The 
study protocol was prepared in accordance 
with the Helsinki Declaration and was 
approved by the Human Experiments Review 
Board of the Department of Biochemistry, 
Kogi State University, Anyigba, Nigeria 
 
Statistical analysis 
Differences between means were checked for 
significance using the one way ANOVA and 
multiple comparison tests. Differences 
between means were significant at p<0.05. 
Analyses were performed using SPSS for 





A total of 542 subjects (268 males and 274 
females) were studied. Of the 268 males, more 
than half (52.2%) had a normal BMI while 
approximately 13% were obese. The 
differences in the ages of the males (Table 1) 
who were thin, over-weight or obese, 
compared to those who had normal BMI were 
not statistically significant (p>0.05). For the 
females, approximately 32% were over-weight 
and about 11% were obese, while more than 
half of the population had normal BMI. As 
was with the males, the differences in ages of 
subjects in the different BMI groups compared 
(Table 1) to those with normal BMI were not 
significant (p > 0.05).  
 
Table 1: Nutritional status of the population 
 Normal (%) Thin (%) p Over-weight (%) p Obese (%) p 
Male (n = 268) 52.2 3.0  32.1  12.7  
Age ± SD (Years) 51.7 ± 12.1 45.6 ± 12.1 0.20 52.8 ± 12.8 1.00 53.0 ± 10.1 0.51 
Female (n = 274) 54.7 2.2  32.1  10.9  
Age ± SD (Years) 48.1 ± 9.5 41.3 ± 15.0 0.32 49.0 ± 9.5 0.46 51.8 ± 8.8 0.44 
Total (n = 542) 53.5 2.6  32.1  11.8  
Age ± SD (Years) 49.8 ± 10.9 43.8 ± 13.0 0.11 50.8 ± 11.5 0.39 52.8 ± 9.1 0.03 
n and SD represent number of subjects and standard deviation respectively. 
 
 
Table 2: Prevalence of hypercholesteroleamia, hyperglyceamia and hypertension distributed according to BMI 
category in the population 
 Hypercholesteroleamia (%) Impaired Glucose Metabolism (%) Hypertension (%) 
 Diabetes Hyperglyceamia  
 male female both male female both male female both male female both 
Thin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.5 16.7 42.9 
Normal 18.6 22.7 20.7 16.4 18.0 17.2 20.0 21.3 20.7 67.9 48.0 57.6 
Over-weight 17.4 23.9 20.7 12.8 15.9 14.4 15.1 19.3 17.2 76.7 61.4 69.0 
Obese 20.6 16.7 18.8 20.6 23.3 21.9 20.6 30.0 25.0 67.6 43.3 56.3 
Total 9.7 13.9 11.8 15.3 17.5 16.4 17.9 21.2 19.6 70.5 51.1 60.7 
Number of subjects = 542 (268 males and 274 females) distributed as follows: thin = 14 (8 males and 6 females); normal = 




A total of 11.8% (9.7% for males and 13.9% 
for females) of the entire population were 
hypercholesterolemic. None of the thin 
subjects (males and females alike) were 
affected by the disorder. Women were more 
affected than men (Table 2). The prevalence of 
hypercholesterolemia (disregarding the thin 
subjects) was highest among over-weight 
women (23.9%) and least among obese 
women (16.7%). 
 
For both males and females, obese subjects 
had the most impaired fasting blood glucose 
profile, followed by normal BMI subjects, 
over-weight subjects and thin subjects, in that 
order. In fact none of the thin subjects had an 
impaired blood glucose metabolism while one 
in four of the obese subjects had an impaired 
FBG. The same trend was noticed for the 
prevalence of diabetes mellitus in the 
population. In each BMI category (except in 
thin subjects), more females were affected by 
diabetes mellitus and/or impaired FBG than 
males (Table 2). 
 
From Table 2, it seen that hypertension was 
very prevalent in the population. 
Approximately 61% of the population (70.5% 
for males and 51.1% for females) was 
hypertensive. The prevalence of hypertension 
was least in thin subjects and highest in over-
weight subjects, while normal BMI and obese 
subjects had similar prevalence rates. In all 
BMI groups, men were markedly more 
hypertensive than women. 
 
Approximately 33% of the obese population 
(26.5% for males and 40.0% for females) were 
metabolically-healthy obese-like (MHO-like). 
More over-weight females (31.8%) than males 
(20.9%) were metabolically-healthy over-
weight-like (MHOW-like).  
 
The same was observed for metabolically-
healthy normal-weight-like subjects in the 
normal BMI group (37.3% for females and 
26.4% for males). On the other hand, more 
males (10.7%) than females (6.7%) having 
normal BMI, were metabolically-obese 
normal-weight-like (MONW-like). Only 5.2% 
of the over-weight population (4.7% for males 
and 5.7% for females) was metabolically-
obese over-weight-like (MOOW-like). Also, 
only 6.3% of the obese population was 
metabolically-obese obese-like (Fig 1).  
 
Fig 1: Prevalence of BMI sub-phenotypes in the 
population. MONW = metabolically-obese normal-
weight-like; MOOW = metabolically-obese over-
weight-like; MOO = metabolically-obese obese-
like; MHNW = metabolically-healthy normal-
weight-like; MHOW = metabolically-healthy over-
weight-like; MHO = metabolically-healthy obese-
like; Number of subjects = 542 (268 males and 274 
females) distributed as follows: thin = 14 (8 males 
and 6 females none of whom had any of the studied 
metabolic disturbances); normal = 290 (140 males 
and 150 females); over-weight = 174 (86 males and 




BMI is an acceptable index for estimating the 
nutritional status of a population2. Thinness is 
often as a result of chronic energy deficiency, 
except in cases of illness, while obesity is an 
indication of excessive energy intake without a 
commensurate level of physical activity. More 
than half of the population we studied had 
normal BMI, suggesting a balance between 
energy intake and expenditure. However, 
about 12% of the population was obese while 
as much as 32% were over-weight. This shows 
that as much as 44% of the population 
weighed more than was desirable. This is 
particularly high when compared to figures 
from the Nigeria demographic and health 
survey22 that reported 15% over-weight and 
5% obesity in women. Our data also shows 
that the males have surpassed the 26% obesity 
prevalence projection of the WHO
23 
for the 
year 2010, while the women were slightly 
below the projected 36% prevalence in 
Nigeria. 
 
More females in our study were 
hypercholesterolemic compared to the males. 
The 9.7% and 13.9% for males and females 




























figures reported elsewhere  in rural Africa (0–
2.8%) but lower than 26–50% reported in 




The 16.4% prevalence of suspected-diabetes 
reported in this study is very high. Reports 
from elsewhere in Africa show a prevalence of 
1% in rural Africa, 5-7% in sub-Saharan 
Africa and between 8% and 13% in more 
developed areas like South Africa
28,29
. This is 
very worrisome especially in view of the 
association of diabetes with such 
macrovascular complications as coronary 
artery disease (CAD), cerebrovascular disease 
and peripheral vascular disease1. The 
prevalence of hyperglyceamia was naturally 
higher than that of suspected-diabetes since 
some individuals had more fasting blood 
glucose than is desirable but were not diabetic. 
 
The prevalence of hypertension in this study 
(60.7%), like suspected-diabetes, is also very 
high. Figures from other parts of Africa are 
lower [19–30%] in population based 
studies
23,25,27
 but slightly higher in hospital-
based samples30,31. The role of hypertension in 
exacerbating cardiovascular diseases is well 
documented in epidemiologic literature. Its 
ability to result in morbidity and mortality 
make this high prevalence rate worrisome 
especially in a population that is battling with 
infectious diseases, like ours. 
 
Our data, more importantly, show that there 
are BMI-metabolic risk sub-phenotypes in 
Nigeria. This is important since it has been 
suggested that the metabolic consequences of 
elevated BMI are the critical factors that 
confer risk for the chronic diseases associated 
with fatness32. The prevalence of MONW-like 
phenotype is put at 3 – 28% depending on the 
definition of metabolic risk and the population 
source
13,33-35]
. Our figure of 8.6% is therefore 
one of the lowest reported. MHO-like 
phenotypes have been reported to occur in 11 
– 28% of some populations
14,33,36,37
. The 32.8% 
prevalence of MHO-like phenotype in our 
study is higher than these. This is instructive 
since it implies that approximately 9% of those 
who had normal BMI were actually at high 
risk of cardiovascular disease (CVD) while as 
much as about 33% of the obese subjects were 
actually at low risk. Meigs and colleagues32 
showed that normal-weight subjects with the 
metabolic syndrome but not obese subjects 
without the metabolic syndrome were at 
substantially elevated risk for CVD over 7-11 
years of follow-up. 
 
Our data further highlights that though only 
8.6% of the normal-weight group was 
metabolically obese-like, only 32.1% of the 
same group had a healthy profile (MHNW-
like) with respect to the parameters measured. 
Furthermore, though only 5.2% of the over-
weight group was metabolically obese-like, 
only 26.4% of the same population was 
MHOW-like. Again, though only 6.3% of the 
obese population was metabolically obese-
like, only 32.8% of that group was MHO-like. 
The implication is that a vast majority of the 
population had one unfavourable metabolic 
index or the other, and may therefore have 
varying degrees of risk of CVD. It has been 
suggested that apparently healthy obese 
individuals may have sub-clinical vascular 
disease
38
. Our data therefore supports the view 
that metabolic factors associated with 
adiposity were more important than fatness 
with respect to the development of CVD and 
the associated morbidities.  
 
Caution must however be exercised in 
interpreting this data especially when 
extrapolating it for the general population. 
This is because our data is not cross-sectional 
and this may have introduced some bias as 
possibly those who knew they were 
hypertensive and needed help were more 
willing to participate in the study. This may 
explain the high prevalence of hypertension in 
the population. Furthermore, we could not 
assay for insulin resistance and all the 
components of the metabolic syndrome in the 
population. This may imply an under-
estimation of the population at risk of these 
disorders. Our study is however fairly large 
and informative, especially as this population 
is rather under-studied. 
 
In conclusion, the prevalence of over-weight 
and obesity in the population is high (44%). 
Hyperglycaemia and hypercholesterolemia 
were significantly prevalent (19.6% and 11.8% 
respectively), while the prevalence of 
hypertension is very high (60.7%). Phenotypes 
of the BMI metabolic risk were present in the 
studied population. We found the MONW-like 
and MOOW-like phenotypes on the one hand 
and MHO-like and MHOW-like phenotypes 
22 
 
on the other hand, at fairly high prevalence 
rates. We conclude that as with other 
populations where these phenotypes have been 
found, the assessment of metabolic risk, 
regardless of BMI, may be better for the 
identification of individuals and groups at risk 
of the development of cardiovascular disease 
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